Netocta Lar Octreotide Long Active Release Injection

Link Copied
13,700.00 / Box

10 Box (MOQ)

Business Type Manufacturer, Exporter, Supplier, Trader
Medicine Type Anti Cancer
Form Injection
Packaging Type Box
Click to view more

Product Details

Composition
Octreotide Long Acting Release
Country of Origin
Made in India
Brand Name Available
Netocta Lar / Netvica Lar/sandostatin Lar / Bd Octerio
Strength Available
20mg & 30mg
Treatment
Severe Diarrhea and other Symptoms that Occur with Certain Intestinal Tumors
Prescription/Non Prescription
Prescription
Storage
2 to 8 Degree
Shelf Life
24 Month

Netocta Lar Octreotide Long Active Release Injection is a medication used to treat certain conditions caused by too much growth hormone in the body. This injectable form of octreotide is designed for long-acting release, providing sustained benefits over an extended period. As a leading Octreotide Long Active Release Injection Manufacturer, Vihari Co Exim is dedicated to producing high-quality pharmaceuticals that meet the needs of patients worldwide.Octreotide Long Active Release Injection Manufacturer: Enhancing Patient Care

As a reputable manufacturer of Octreotide Long Active Release Injections, Vihari Co Exim ensures strict adherence to quality standards and regulations. Each batch of 

Netocta Lar Octreotide undergoes rigorous testing to guarantee potency, purity, and efficacy. By utilizing advanced manufacturing processes and state-of-the-art facilities, Vihari Co Exim delivers a reliable product that healthcare providers can trust.

Benefits of Netocta Lar Octreotide Long Active Release Injection

Netocta Lar Octreotide offers several advantages for patients requiring long-term treatment. Its sustained release formulation allows for less frequent dosing, improving convenience and compliance. Additionally, this medication helps regulate hormone levels, alleviating symptoms and improving quality of life for individuals with conditions such as acromegaly.

Conclusion

In conclusion, Netocta Lar Octreotide Long Active Release Injection manufactured by Vihari Co Exim is a vital treatment option for patients in need of sustained hormone regulation.

 

Octreotide long-acting injection is used to control acromegaly, carcinoid tumors, and VIP-omas in people who have been successfully treated with octreotide injection but prefer to receive injections less often.


Octreotide LAR is approved for treatment of acromegaly after surgery if the disease is not controlled. This study was aimed to test the safety and efficacy of octreotide LAR in acromegalic patients who did not have any previous treatment for acromegaly.


Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or VIPomas) or metastatic carcinoid tumors (tumors that has already spread in the body). It does not cure the tumor but it helps the patient feel more comfortable.

Yes! I am interested

Looking for "Netocta Lar Octreotide Long Active Release Injection" ?

Box

Our Blogs


Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us